IOSP Logo.jpg
Innospec Schedules Third Quarter 2024 Earnings Release and Conference Call
October 07, 2024 16:45 ET | Innospec Inc.
ENGLEWOOD, Colo., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2024 earnings results on Tuesday, November 5, 2024 after market...
INN_LogoTag_RGB.jpg
InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2024
September 10, 2024 16:05 ET | InnovAge
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR ENDED JUNE 30, 2024
agrify_logo_block.jpg
Agrify Corporation Announces Results for Second Quarter 2024 and Amended Results for First Quarter 2024
August 14, 2024 16:35 ET | Agrify
Agrify Corporation Announces Results for Second Quarter 2024 and Amended Results for First Quarter 2024
OMNIQ
OMNIQ Schedules Second-Quarter 2024 Earnings Call
August 13, 2024 08:30 ET | omniQ Corp.
OMNIQ schedules second-quarter earnings release followed by a live earnings call with management on August 15, 2024.
Rumble Reports Second Quarter 2024 Results
August 12, 2024 16:05 ET | Rumble, Inc.
~ Delivers Sequential Revenue Growth of 27% to $22.5 Million ~ ~ Introduces New KPI, Average Revenue Per User (ARPU), Up 19% Over First Quarter ~ LONGBOAT KEY, Fla., Aug. 12, 2024 (GLOBE...
NIU.jpg
Niu Technologies Announces Unaudited Second Quarter 2024 Financial Results
August 12, 2024 03:00 ET | NIU Technologies
-- Second Quarter Revenues of RMB 940.5 million, an increase of 13.5% year-over-year -- Second Quarter Net Loss of RMB 24.9 million, compared to Net Loss of RMB 1.9 million in the same period...
MNPR Triangle 2.JPG
Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
August 09, 2024 08:00 ET | Monopar Therapeutics Inc.
Initiated and Enrolling Patients into MNPR-101-Zr First-in-Human Phase 1 Radiopharma Clinical Trial MNPR-101 radio-immuno-therapeutic (RIT) Clinical Trial on Track to Initiate in Q4 2024 ...
Logo.PNG
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
August 08, 2024 19:20 ET | HilleVax, Inc.
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus vaccine...
Pacific Health Care Organization, Inc. Reports its Second Quarter 2024 Results
August 08, 2024 17:05 ET | Pacific Health Care Organization, Inc.
Irvine, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) yesterday filed with the Securities and Exchange Commission (the “Commission”) its...
blk_parkerlogo.jpg
Parker Reports Fiscal 2024 Fourth Quarter and Full Year Results and Issues Guidance for Fiscal 2025
August 08, 2024 07:30 ET | Parker-Hannifin Corporation
CLEVELAND, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today reported results for the quarter and year ended...